In addition to their anti-inflammatory function [66], PPAR and PPAR agonists have been shown to treat dyslipidaemia or type II diabetes, respectively [67], which could correlate to the phytochemicals in the Polyalthia genus with an anti-inflammatory characteristic. Here, PPARA is linked to inherited lipid metabolism disorder.